SC 13D/A | 2012-01-27 | Longitude Capital Partners, LLC | Jazz Pharmaceuticals plc | 0 | 0.0% | EDGAR |
SC 13D | 2012-01-27 | Longitude Capital Partners, LLC | Jazz Pharmaceuticals plc | 3,831,924 | 6.7% | EDGAR |
SC 13D | 2012-01-27 | KKR Fund Holdings L.P. | Jazz Pharmaceuticals plc | 10,504,338 | 19.1% | EDGAR |
SC 13G/A | 2011-10-07 | BlackRock Inc. | JAZZ PHARMACEUTICALS INC | 1,458,258 | 3.5% | EDGAR |
SC 13D/A | 2011-09-30 | Longitude Capital Partners, LLC | JAZZ PHARMACEUTICALS INC | 3,831,924 | 9.0% | EDGAR |
SC 13D/A | 2011-09-29 | Longitude Capital Partners, LLC | JAZZ PHARMACEUTICALS INC | 3,831,924 | 9.0% | EDGAR |
SC 13D | 2011-09-28 | Azur Pharma Ltd | JAZZ PHARMACEUTICALS INC | 18,181,395 | 43.2% | EDGAR |
SC 13G/A | 2011-02-15 | LEHMAN BROTHERS HOLDINGS INC | JAZZ PHARMACEUTICALS INC | 1,337,941 | 3.3% | EDGAR |
SC 13G/A | 2011-02-14 | Versant Affiliates Fund II-A, LP | JAZZ PHARMACEUTICALS INC | 30,724 | 0.1% | EDGAR |
SC 13G/A | 2011-02-14 | BRIDGER MANAGEMENT LLC | JAZZ PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G | 2011-02-04 | BlackRock Inc. | JAZZ PHARMACEUTICALS INC | 3,458,174 | 8.9% | EDGAR |
SC 13G | 2010-02-16 | Versant Affiliates Fund II-A, LP | JAZZ PHARMACEUTICALS INC | 30,724 | 0.9% | EDGAR |
SC 13G/A | 2010-02-12 | BRIDGER MANAGEMENT LLC | JAZZ PHARMACEUTICALS INC | 1,942,050 | 6.3% | EDGAR |
SC 13G/A | 2010-02-12 | SWIFTCURRENT OFFSHORE LTD. | JAZZ PHARMACEUTICALS INC | 835,250 | 2.7% | EDGAR |
SC 13G/A | 2010-02-11 | PROSPECT VENTURE PARTNERS II LP | JAZZ PHARMACEUTICALS INC | 1,510,145 | 4.9% | EDGAR |
SC 13G/A | 2010-01-21 | Jazz Investors, LLC | JAZZ PHARMACEUTICALS INC | 1,621,659 | - | EDGAR |
SC 13G/A | 2009-10-13 | KKR JP LLC | JAZZ PHARMACEUTICALS INC | 10,504,338 | 33.9% | EDGAR |
SC 13D | 2009-07-14 | Longitude Capital Partners, LLC | JAZZ PHARMACEUTICALS INC | 2,843,601 | 8.9% | EDGAR |
SC 13G/A | 2009-02-17 | ADAGE CAPITAL PARTNERS GP LLC | JAZZ PHARMACEUTICALS INC | 1,333,821 | 4.6% | EDGAR |
SC 13G/A | 2009-02-17 | KKR JP LLC | JAZZ PHARMACEUTICALS INC | 10,504,338 | 35.8% | EDGAR |